Saraswanti Indoland Development Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Saraswanti Indoland Development Tbk. trades at Rp92 (market cap 490.04B, 1.51M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 23.8× Saraswanti Indoland Development Tbk.'s market cap, and Saraswanti Indoland Development Tbk. is more actively traded (1.51M versus 429.7K). Which is the better fit depends on your goals.
| SWID | TSPC | |
|---|---|---|
Market Cap | 490.04B | 11.68T |
Volume | 1.51M | 429.7K |
Lot | 15.14K | 4.3K |
Turnover | 137.63M | 1.11B |
Average Price | 90.94 | 2,591.65 |
Value | 137.63M | 1.11B |
Indicative Equilibrium Price | 92 | 2,580 |
Indicative Equilibrium Volume | 1.49K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Read more on SWID →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →